Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential - Forecast to 2023

  • Report Code : 368321
  • Pages : 120
  • Published On : Feb 2018
  • Industry : Healthcare and Pharmaceuticals
  • Format :

Choose License Type

Single User License: US$ 2,000
Multi User License: US$ 0
Corporate User License: US$ 3,000
Executive Summary

The report titled "Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential - Forecast to 2023" presents the market potential of six major pipeline drugs meant for the treatment of Psoriasis. These six drugs that fall in the various categories of Injectables, Oral pills and Topical creams/lotions by mode of administration have been recognized as being clinically effective in Psoriasis treatment. Expected to be launched in the market within the next 4-5 years, these six potential drugs are likely to bring about major changes in the way psoriasis is treated globally.

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Psoriasis Pipeline Drugs Market by assessing the potential of the six drugs that will be launched in the near future. Also, the report assesses the results of various clinical trials undertaken for each of the six drugs, the product profile, description and regulatory phase of each of the six drugs. Also, 7Ps Analysis (Patent, Phase, Pathway, Patient, Physician, Payer, Partner) has been done for each of the six drugs to present the current perspective.

Over the recent years, the Psoriasis Drugs market is growing rapidly due to rising prevalence of Psoriasis patients around the world. Globally, the growth of Psoriasis Drugs market is driven by rising psoriatic population. The global psoriasis drugs market is projected to display a robust growth during 2019- 2023, chiefly driven by low efficacy and tolerability of present psoriasis drugs and improved safety and efficacy of investigational drugs.

The report has covered and analysed the major psoriasis drugs that are in pipeline and expected to be launched in the near future. The product profile, assessment of clinical trials, the regulatory phases and the potential of the drugs has been analysed in the report. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decision. The report titled "Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential - Forecast to 2023" also analyzes the incidences of psoriasis in countries like United States, United Kingdom, France, Italy, Spain, Germany and Norway.


Scope of the Report

Psoriasis Pipeline Drugs Assessment - Drug X1, X2, X3, X4, X5, X6 (Forecast Period: 2019-2023)
• Market Potential
• Clinical Trials
• Product Description
• Regulatory Phases
• 7Ps Analysis

Country Analysis - US, UK, France, Italy, Spain, Germany and Norway (Forecast Period: 2019-2023)
• Incidence of Psoriasis

Other Report Highlights
• Company Analysis - UCB, Sun Pharmaceutical Industries Ltd, Boehringer Ingelheim, Forward Pharma, Almirall and Valeant Pharmaceuticals

Customization of the Report
The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.
Table of Contents 1. Research Methodology 2. Psoriasis - An Overview 2.1. Symptoms of Psoriasis 2.2. Types of Psoriasis 2.3. Causes of Psoriasis 2.4. Triggers, Risk Factors and Complications of Psoriasis 3. Diagnosis of Psoriasis 4. Treatment of Psoriasis 5. Anti-Psoriasis Pipeline Drugs 5.1. Anti-Psoriasis Pipeline Drugs - Cimzia (Certolizumab Pegol) 5.1.1. Description 5.1.2. Regulatory Milestones 5.1.3. Advantages & Disadvantages 5.1.4. Product Profile & Launch Date 5.1.5. Clinical Trials and Status 5.1.6. Pivotal Clinical Trials and Results 5.1.7. Cimzia (Certolizumab Pegol) - Global Market Potential 5.1.8. Cimzia (Certolizumab Pegol) - 7Ps Analysis 5.2. Anti-Psoriasis Pipeline Drugs - Tildrakizumab (MK-3222) 5.2.1. Description 5.2.2. Regulatory Milestones 5.2.3. Advantages & Disadvantages 5.2.4. Product Profile & Launch Date 5.2.5. Clinical Trials and Status 5.2.6. Pivotal Clinical Trials and Results 5.2.7. Tildrakizumab (MK-3222)- Global Market Potential 5.2.8. Tildrakizumab (MK-3222)- 7Ps Analysis 5.3. Anti-Psoriasis Pipeline Drugs - Risankizumab (BI 655066) 5.3.1. Description 5.3.2. Regulatory Milestones 5.3.3. Advantages & Disadvantages 5.3.4. Product Profile & Launch Date 5.3.5. Clinical Trials and Status 5.3.6. Pivotal Clinical Trials and Results 5.3.7. Risankizumab (BI 655066)- Global Market Potential 5.3.8. Risankizumab (BI 655066)- 7Ps Analysis 5.4. Anti-Psoriasis Pipeline Drugs - FP187 5.4.1. Description 5.4.2. Regulatory Milestones 5.4.3. Advantages & Disadvantages 5.4.4. Product Profile & Launch Date 5.4.5. Clinical Trials and Status 5.4.6. Pivotal Clinical Trials and Results 5.4.7. FP187 - Global Market Potential 5.4.8. FP187 - 7Ps Analysis 5.5. Anti-Psoriasis Pipeline Drugs - Skilarence (LAS41008) 5.5.1. Description 5.5.2. Regulatory Milestones 5.5.3. Advantages & Disadvantages 5.5.4. Product Profile & Launch Date 5.5.5. Clinical Trials and Status 5.5.6. Pivotal Clinical Trials and Results 5.5.7. Skilarence (LAS41008) - Global Market Potential 5.5.8. Skilarence (LAS41008) - 7Ps Analysis 5.6. Anti-Psoriasis Pipeline Drugs - Duobrii (IDB 118) 5.6.1. Description 5.6.2. Regulatory Milestones 5.6.3. Advantages & Disadvantages 5.6.4. Product Profile & Launch Date 5.6.5. Clinical Trials and Status 5.6.6. Pivotal Clinical Trials and Results 5.6.7. Duobrii (IDB 118) - Global Market Potential 5.6.8. Duobrii (IDB 118) - 7Ps Analysis 6. Company Profiles 6.1. UCB 6.2. Sun Pharmaceutical Industries Ltd 6.3. Boehringer Ingelheim 6.4. Forward Pharma 6.5. Almirall 6.6. Valeant Pharmaceuticals 7. Number of Psoriasis Patients By Country 7.1. U.S 7.2. U.K 7.3. France 7.4. Italy 7.5. Germany 7.6. Norway

mRNA Vaccine Drugs Development Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The mRNA Vaccine Drugs Development Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...

Asia Pacific Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Photodynamic Therapy Market is on the brink of significant growth, driven by increasing cancer prevalence, advancements in Photodynamic Therapy technology, and rising awareness about minimally invasive treatment options. Market research indicates a robus...

Europe Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Photodynamic Therapy Market is poised for substantial growth in the coming decade, propelled by increasing cancer incidence, advancements in photodynamic therapy technology, and heightened awareness of minimally invasive treatments. Market research forecasts t...

North America Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The North America Photodynamic Therapy Market is projected to witness substantial growth in the coming decade, driven by the rising prevalence of cancer, advancements in Photodynamic Therapy technology, and increasing awareness of minimally invasive treatments. Market re...

Global Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Global Photodynamic Therapy Market is poised to experience substantial growth in the coming decade, driven by the rising prevalence of cancer and other chronic diseases, advancements in PDT technology, and increasing awareness of minimally invasive treatment options....

Medicine Pipeline Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Medicine Pipeline Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/pla...

Mobile Pipeline Welding Robot Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Mobile Pipeline Welding Robot Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manuf...

Smart Pipeline Network Solutions Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Smart Pipeline Network Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...

Drugs Produced by Fermentation Engineering Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Drugs Produced by Fermentation Engineering Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...

Drugs of Abuse Testing Products Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Drugs of Abuse Testing Products Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...